Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
NCT ID: NCT01836042
Last Updated: 2016-04-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
108 participants
OBSERVATIONAL
2013-07-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
NCT04624685
iStent Inject New Enrollment Post-Approval Study
NCT04624698
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
NCT04900844
The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
NCT05757505
Peripherally Inserted Central Catheter Placement by Interventional Radiologists Using the Sonic Flashlight
NCT00226213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Randomized iStent
Implantation of one iStent in conjunction with cataract surgery, patients randomized to group
No interventions assigned to this group
Randomized cataract surgery
Cataract surgery alone, patients randomized to group
No interventions assigned to this group
Non-randomized iStent
Implantation of one iStent in conjunction with cataract surgery, patients not randomized to group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients not previously enrolled in Glaukos Study GC-003
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glaukos Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeff Wells, PharmD, MBA
Role: STUDY_DIRECTOR
Glaukos Corporation
Jay Katz, MD
Role: STUDY_CHAIR
Wills Eye Institute; Thomas Jefferson University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beverly Hills, California, United States
Petaluma, California, United States
Sacramento, California, United States
San Clemente, California, United States
Santa Maria, California, United States
Parker, Colorado, United States
Boynton Beach, Florida, United States
Miami, Florida, United States
Tampa, Florida, United States
Morrow, Georgia, United States
Indianapolis, Indiana, United States
Overland Park, Kansas, United States
Louisville, Kentucky, United States
Baton Rouge, Louisiana, United States
Saint Joseph, Michigan, United States
Bloomington, Minnesota, United States
Edina, Minnesota, United States
Independence, Missouri, United States
Kansas City, Missouri, United States
Las Vegas, Nevada, United States
Winston-Salem, North Carolina, United States
Cincinnati, Ohio, United States
Brookville, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Beaumont, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GTS100-PAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.